<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03079596</url>
  </required_header>
  <id_info>
    <org_study_id>B-1608-357-006</org_study_id>
    <nct_id>NCT03079596</nct_id>
  </id_info>
  <brief_title>ERAS (Early Recovery After Surgery) Protocol After Laparoscopic Total Gastrectomy</brief_title>
  <official_title>Comparison of ERAS (Early Recovery After Surgery) Protocol With Conventional Protocol After Laparoscopic Total Gastrectomy: A Prospective Randomized Controlled Trial (Phase II Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Enhanced Recovery After Surgery (ERAS) programs have been introduced with purposes of
      reducing the surgical stress response and obtaining optimal recovery after surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is strong evidence of the usefulness of the ERAS programs in patients undergoing
      colorectal surgery in terms of significantly reduced postoperative complications and shorter
      length of hospital stay, compared to the patients of conventional treatment.

      However, few studies exist about the implication of ERAS programs in the laparoscopic
      gastrectomy.

      The aim of this study was to compare the recovery rate, morbidity, and quality of life in the
      patients undergoing laparoscopic total gastrectomy for gastric cancer, receiving either ERAS
      protocol or conventional postoperative cares.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tolerance of diet for 24 hours</measure>
    <time_frame>4 days after surgery</time_frame>
    <description>Tolerance of diet for 24 hours. Able to eat one third of more of soft-blend meal without abdominal discomfort, bloating, nausea, or vomiting</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Analgesic-free</measure>
    <time_frame>4 days after surgery</time_frame>
    <description>Analgesic-free (oral or IV analgesic drugs not necessary after cessation of PCA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safe ambulation</measure>
    <time_frame>4 days after surgery</time_frame>
    <description>Safe ambulation (ambulation of 600m without assistance)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Afebrile status without major complications</measure>
    <time_frame>4 days after surgery</time_frame>
    <description>Afebrile status without major complications (fever defined as body temperature greater than 37.5)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative length of hospital stay</measure>
    <time_frame>up to 4 weeks after surgery</time_frame>
    <description>Postoperative length of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to tolerance of a full diet</measure>
    <time_frame>up to 1 month after surgery</time_frame>
    <description>Time to tolerance of a full diet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first bowel motion</measure>
    <time_frame>up to 7 days after surgery</time_frame>
    <description>Time to first bowel motion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>ERAS perioperative cares</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients planned to undergoing laparoscopic total gastrectomy, following the ERAS protocols</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional perioperative cares</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patents will be managed by our hospital's critical pathways</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS perioperative cares</intervention_name>
    <description>Patient's preoperative counseling &amp; education before surgery No Bowel preparation Oral Carbohydrate Solution (OCS) loading until 2hours before surgery Fluid restriction &amp; Management by pulse contour analysis or transesophageal doppler Early mobilization Early oral feeding (postoperative 1 day - sips of water, 2 days - semifluid diet (SFD), 3 days - soft blended diet (SBD)) Epidural patient controlled analgesics (no opioids analgesics) Postoperative Nausea Active Control Thromboembolism prophylaxis by low molecular weighted heparin (LMWH) Perioperative High content Oxygen therapy No drain insertion No Levin tube Patients will be discharged at POD#4 if there's no problem.</description>
    <arm_group_label>ERAS perioperative cares</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional perioperative cares</intervention_name>
    <description>No Patient's preoperative counseling &amp; education before surgery Bowel preparation No Oral Carbohydrate Solution (OCS) loading until 2hours before surgery Conventional Fluid Management by clinical signs (Urine output, heart rate etc.) Conventional Mobilization Conventional oral feeding (POD#2 SOW, #3 SFD, #4 SBD) IV PCA Postoperative Nausea Control if needed No Thromboembolism prophylaxis No or Low Content Oxygen therapy Routine drain insertion Levin tube insertion if needed</description>
    <arm_group_label>Conventional perioperative cares</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective surgery

          -  American Society of Anesthesiologists (ASA) scores &lt; 3

          -  Gastric cancer, adenocarcinoma, possible to perform laparoscopic total gastrectomy

          -  Informed consent

          -  No other treatment (Radiation, Chemotherapy or Immunotherapy) on this gastric cancer
             or other type of cancer.

          -  No systemic inflammatory disease

        Exclusion Criteria:

          -  conversion to open
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>68 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyung-Ho Kim, M.D. Ph.D.</last_name>
      <phone>+82-31-787-7095</phone>
      <email>hhkim@snubh.org</email>
    </contact>
    <contact_backup>
      <last_name>Ju-Hee Lee, M.D.</last_name>
      <phone>+82-31-787-7090</phone>
      <email>leejuhee79@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Hyung-Ho Kim, M.D.Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2017</study_first_submitted>
  <study_first_submitted_qc>March 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2017</study_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Sang-Hoon Ahn</investigator_full_name>
    <investigator_title>Profesor</investigator_title>
  </responsible_party>
  <keyword>gastric cancer</keyword>
  <keyword>ERAS (early recovery after surgery)</keyword>
  <keyword>laparoscopic total gastrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

